cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

download cardiomiopatii CLASIFICARI  NONCOMPACT TAKOTSUBO.pdf

of 36

Transcript of cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    1/36

    CURSURI CARDIOLOGIE

    Pentru

    STUDENTI & MEDICI

    2012-2013

    Conf. Dr. Ioan BostacaUniversitatea de MedicinGr.T.Popa IASI

    CURS 9/29 X 2012

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    2/36

    Report of the 1995 World Health

    Organization/International Society and Federation of

    Cardiology Task Force on the Definition andClassification of Cardiomyopathies

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    3/36

    Hypertensive cardiomyopathyoften presents with left ventricular hypertrophy in

    association with features of dilated or restrictive cardiomyopathy with cardiac failure.

    Inflammatory cardiomyopathyis defined by myocarditis in association with cardiac

    dysfunction. Myocarditis is an inflammatory disease of the myocardium and isdiagnosed by established histological, immunological, and immunohistochemical

    criteria. Idiopathic, autoimmune, and infectious forms of inflammatory

    cardiomyopathy are recognized. Inflammatory myocardial disease is involved in the

    pathogenesis of dilated cardiomyopathy and other cardiomyopathies, eg, Chagas'

    disease, HIV, enterovirus, adenovirus, and cytomegalovirus.13

    Metabolic cardiomyopathyincludes the following categories: Endocrine, eg,thyrotoxicosis, hypothyroidism, adrenal cortical insufficiency, pheochromocytoma,

    acromegaly, and diabetes mellitus; familial storage disease and infiltrations, eg,

    hemochromatosis, glycogen storage disease, Hurler's syndrome, Refsum's

    syndrome, Niemann-Pick disease, Hand-Schller-Christian disease, Fabry-Anderson

    disease, and Morquio-Ullrich disease; deficiency, eg, disturbances of potassium

    metabolism, magnesium deficiency, and nutritional disorders such as kwashiorkor,anemia, beri-beri, and selenium deficiency; amyloid, eg, primary, secondary, familial,

    and hereditary cardiac amyloidoses, familial Mediterranean fever, and senile

    amyloidosis.

    Report of the 1995 World Health

    Organization/International Society and Federation ofCardiology Task Force on the Definition and

    Classification of Cardiomyopathies

    http://www.besancon-cardio.net/pro/recommandations/classif_c.htmhttp://www.besancon-cardio.net/pro/recommandations/classif_c.htm
  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    4/36

    Hypertensive cardiomyopathyoften presents with left ventricular hypertrophy in

    association with features of dilated or restrictive cardiomyopathy with cardiac failure.

    Inflammatory cardiomyopathyis defined by myocarditis in association with cardiac

    dysfunction. Myocarditis is an inflammatory disease of the myocardium and isdiagnosed by established histological, immunological, and immunohistochemical

    criteria. Idiopathic, autoimmune, and infectious forms of inflammatory

    cardiomyopathy are recognized. Inflammatory myocardial disease is involved in the

    pathogenesis of dilated cardiomyopathy and other cardiomyopathies, eg, Chagas'

    disease, HIV, enterovirus, adenovirus, and cytomegalovirus.13

    Metabolic cardiomyopathyincludes the following categories: Endocrine, eg,thyrotoxicosis, hypothyroidism, adrenal cortical insufficiency, pheochromocytoma,

    acromegaly, and diabetes mellitus; familial storage disease and infiltrations, eg,

    hemochromatosis, glycogen storage disease, Hurler's syndrome, Refsum's

    syndrome, Niemann-Pick disease, Hand-Schller-Christian disease, Fabry-Anderson

    disease, and Morquio-Ullrich disease; deficiency, eg, disturbances of potassium

    metabolism, magnesium deficiency, and nutritional disorders such as kwashiorkor,anemia, beri-beri, and selenium deficiency; amyloid, eg, primary, secondary, familial,

    and hereditary cardiac amyloidoses, familial Mediterranean fever, and senile

    amyloidosis.

    http://www.besancon-cardio.net/pro/recommandations/classif_c.htmhttp://www.besancon-cardio.net/pro/recommandations/classif_c.htm
  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    5/36

    General system disease includes connective tissue

    disorders, eg, systemic lupus erythematosus, polyarteritis

    nodosa, rheumatoid arthritis, scleroderma, and

    dermatomyositis. Infiltrations and granulomas include

    sarcoidosis and leukemia.Muscular dystrophies include Duchenne, Becker-type,

    and myotonic dystrophies.

    Neuromuscular disorders include Friedreich's ataxia,

    Noonan's syndrome, and lentiginosis.Sensitivity and toxic reactions include reactions to

    alcohol, catecholamines, anthracyclines, irradiation, and

    miscellaneous.

    Alcoholic cardiomyopathy may be associated with a heavy

    alcohol intake. At present we cannot define a causal versus a

    conditioning role of alcohol or apply precise diagnostic

    criteria.

    Peripartal cardiomyopathy may first manifest in the

    peripartum period. This is probably a heterogeneous group.

    Report of the 1995 World Health

    Organization/International Society and Federation of

    Cardiology Task Force on the Definition andClassification of Cardiomyopathies

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    6/36

    General system disease includes connective tissue

    disorders, eg, systemic lupus erythematosus, polyarteritis

    nodosa, rheumatoid arthritis, scleroderma, and

    dermatomyositis. Infiltrations and granulomas include

    sarcoidosis and leukemia.Muscular dystrophies include Duchenne, Becker-type,

    and myotonic dystrophies.

    Neuromuscular disorders include Friedreich's ataxia,

    Noonan's syndrome, and lentiginosis.Sensitivity and toxic reactions include reactions to

    alcohol, catecholamines, anthracyclines, irradiation, and

    miscellaneous.

    Alcoholic cardiomyopathy may be associated with a heavy

    alcohol intake. At present we cannot define a causal versus a

    conditioning role of alcohol or apply precise diagnostic

    criteria.

    Peripartal cardiomyopathy may first manifest in the

    peripartum period. This is probably a heterogeneous group.

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    7/36

    Clasificarea CARDIOMIOPATIILOR (dup OMS, 1996)

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    8/36

    CLASIFICARE CLASIC

    1. cardiomiopatii dilatative;2. cardiomiopatii hipertrofice (cu obstruc]ie sau f\r\

    obstruc]ie): cardiomiopatia hipertrofic\ obstructiv\; cardiomiopatia hipertrofic\ neobstructiv\;

    3. cardiomiopatia restrictiv\.

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    9/36

    CLASIFICARE(minimal, elementar)

    Dilatativ\

    Hipertrofic\

    Restrictiv\

    CM (displazia) aritmogen\ a VD

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    10/36

    DIMENSIUNI NORMALE CMD

    CMH CMR

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    11/36

    Clasificarea CARDIOMIOPATIILOR (etiopatogenic) dup AHA

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    12/36

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    13/36

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    14/36

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    15/36

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    16/36

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    17/36

    Clasificarea CARDIOMIOPATIILOR (etiopatogenic) dup AHA

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    18/36

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    19/36

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    20/36

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    21/36

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    22/36

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    23/36

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    24/36

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    25/36

    ESC, Working Group on myocardial and pericardial diseases, 2008

    Clasificare etiologic\:

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    26/36

    Clasificare etiologic\:A. Cardiomiopatii dilatative primitive (idiopatice).B. Cardiomiopatii dilatative secundare: cardiomiopatii inflamatorii:

    infec]ioase (virusuri, bacterii, fungi); neinfec]ioase (colagenoze, granulomatoze).

    cardiomiopatii nutri]ionale: avitaminoza B1; pelagra; scorbutul; deficitul de seleniu.

    cardiomiopatii din boli endocrine [i metabolice: diabet zaharat (cardiomiopatia diabetic\); uremie (cardiomiopatia uremic\); tireotoxicoza (cardiotireoza); mixedem; feocromocitom (cardiomiopatia adrenergic\); acromegalia;

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    27/36

    Tablou clinicSimptomatologia se dezvolt\ lent, cu manifest\ri progresive de insuficien]\ cardiac\

    stng\ [i dreapt\:

    simptome de insuficien]\ cardiac\ stng\: dispnee, oboseal\, sl\biciunemuscular\. semne de insuficien]\ cardiac\ dreapt\:edeme;hepatomegalie;jugulare turgescente.Alte semne [i simptome: tahicardie sinusal\; sufluride insuficien]\ mitral\ sau tricuspidian\ (organo-func]ionale); galop atrial, ventricular sau de suma]ie.

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    28/36

    Alte elemente clinice sugestive pentru cardiomiopatie dilatativ\ primitiv\

    (idiopatic\): existen]a n antecedentele pacientului a unor frecvente st\ri gripale

    (miocardit\ cronic\); formare de trombusuri intracavitare, ce favorizeaz\ apari]ia emboliilor (siste-

    mice sau pulmonare); comportamentul refractarla tratamentul clasic al insuficien]ei cardiace; vulnerabilitatea miocardului la tratamentul cu digital\, realiznd rapid

    manifest\ri de intoxica]ie digitalic\ relativ\ (uneori aritmii amenin]\toare pentru

    via]\),nainteaob]inerii efectului terapeutic scontat prin digitalizare optimal\.

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    29/36

    Explor\ri paraclinice1. Electrocardiogramaarat\ modific\ri nespecifice: tahicardie sinusal\; tulbur\ri de ritm ectopice: fibrila]ie atrial\; aspect de Q sau QS nderiva]iile V1-V4 sau nV5-V6

    (aspect pseudo-infarct); anomalii ale segmentului ST [i ale undei T: subdenivelare de ST [i und\

    T negativ\; tulbur\ri de conducere:

    bloc de ram stng;blocuri atrio-ventriculare.

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    30/36

    2. Radiografia toracic\relev\:

    cardiomegalie (ICT peste 0,55); staz\ venoas\ pulmonar\; radiografiile seriate arat\ progresia (evolu]ia natural\ defavorabil\) sau

    regresia ICT (amelior\ri pasagere).

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    31/36

    3.Ecocardiografia: exclude alt\ boal\ ce evolueaz\ cu cardiomegalie; determin\ gradul de afectare a func]iei sistolice ventriculare; poate urm\ri ntimp evolu]ia bolii.

    Modific\rile ecocardiografice sugestive pentru cardiomiopatie

    dilatativ\ sunt:

    hipokinezia difuz\ mai mult sau mai pu]in sever\; pere]i sub]iri; m\rirea diametrelor camerelor ventriculare; trombusuri intracavitare.

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    32/36

    Caracteristice pentru sc\derea debitului cardiacsunt: deschiderea limitat\ a valvei mitrale n diastol\,datorit\ unui flux transmitral sc\zut nchiderea sistolic\ incomplet\ a valvei mitrale

    datorit\ cre[terii necorespunz\toare a presiunii dinventriculul stng; nchiderea precoce a valvei aortice datorit\

    sc\derii ejec]iei ventriculului insuficient.Determin\ri Eco-cantitative privind performan]acardiac\: m\surarea frac]iei de ejec]ie;

    m\surarea frac]iei de scurtare; eviden]ierea regurgita]iei mitrale sau

    tricuspidiene.

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    33/36

    4.Angiocardiografia nuclear\, RMN (IRM)

    - debitul cardiac,- frac]ia de ejec]ie, frac]ia de scurtare (cu o preciziemai mare dectecocardiografia)

    5. Scintigrafia miocardic\efectuat\ cu diferite substan]eradiofarmaceutice poate exclude cardiopatia ischemic\.6.Cateterismul cardiacpoate determina, nplus,- presiunile telediastolice ventriculare, utile n

    aprecierea disfunc]iei ventriculilor.- angiografia coronarian\ este normal\ (exclude

    cardiomiopatia ischemic\ cu insuficien]\ cardiac\)

    7. Biopsia endomiocardic\ este util\ n confirmareaunor boli specifice miocardice, cum ar fi sarcoidoza sauhemocromatoza.

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    34/36

    Report of the 1995 World Health

  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    35/36

    Specific ardiomyopathies

    Definition and lassificationSpecific ardiomyopathies

    References

    The term specific cardiomyopathies is now used to describe heartmuscle diseases that are

    associated with specific cardiac orsystemic disorders. These were previously defined as specificheart

    muscle diseases.

    Ischemic cardiomyopathypresents as a dilated cardiomyopathywith impaired contractile performancenot explained by the extentof coronary artery disease or ischemic damage.

    Valvular cardiomyopathypresents with ventricular dysfunctionthat is out of proportion to the abnormal

    loading conditions.

    Report of the 1995 World Health

    Organization/International Society and Federation of

    Cardiology Task Force on the Definition and

    Classification of Cardiomyopathies

    http://www.besancon-cardio.net/pro/recommandations/classif_c.htmhttp://www.besancon-cardio.net/pro/recommandations/classif_c.htmhttp://www.besancon-cardio.net/pro/recommandations/classif_c.htm
  • 8/14/2019 cardiomiopatii CLASIFICARI NONCOMPACT TAKOTSUBO.pdf

    36/36